Expands epinephrine administration mechanisms permitted in schools.
Impact
The amendment to the existing legislation (P.L.1997, c.368) will require each school district and nonpublic school to develop policies that comply with updated guidelines laid out by the Department of Education. Schools are mandated to ensure that trained personnel, such as the school nurse and designated staff, are available to administer epinephrine. The bill also emphasizes that schools must keep a supply of FDA approved epinephrine devices readily accessible for emergency use, intending to enhance student safety and ensure prompt response to allergic reactions.
Summary
Bill A181, titled 'An Act concerning the administration of epinephrine in schools,' seeks to enhance the mechanisms through which schools can administer epinephrine during emergencies, specifically in cases of anaphylaxis. The key change proposed in this legislation is the expansion of allowed methods for epinephrine administration beyond just pre-filled auto-injectors to include any FDA approved mechanisms. This aims to provide flexibility in emergency situations, ensuring that schools can respond effectively with the appropriate medical tools available.
Contention
Notably, the bill addresses liability concerns by stipulating that parents or guardians must provide written consent for the administration of epinephrine, acknowledging that the school and its employees will not be liable for any injuries resulting from the administration. This could be a point of contention as it shifts some level of responsibility onto families while aiming to protect schools from legal repercussions associated with emergency treatments. Overall, while the bill seeks to improve safety protocols, it also raises discussions around parental consent and the implications of liability waivers.